Sign in
4

Changes in Ownership

BioAtla, Inc. Filed Acc 0001209191-22-012942

Options or other derivatives

  • Chief Financial Officer acquired 115,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
WALDRON RICHARD A Chief Financial Officer 2022-02-21 Grant or award · Employee Stock Option (right to buy) +115,000 115,000 D
Loading xslF345X03/doc4.xml…